Kantonsspital St.Gallen
login

publications

Philipp Kohler

title  
 
Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022;.
   
Seneghini M, Rüfenacht S, Babouee Flury B, Flury D, Schlegel M, Kuster S, Kohler P. It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review. Antimicrobial Stewardship & Healthcare Epidemiology 2022;.
   
Haller S, Güsewell S, Egger T, Scanferla G, Thoma R, Leal-Neto O B, Flury D, Brucher A, Lemmenmeier E, Möller J C, Rieder P, Rütti M, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kahlert C R, Kohler P. Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort. Antimicrob Resist Infect Control 2022; 11:27.
   
Strahm C, Seneghini M, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J C, Rieder P, Ruetti M, Rutz R, Schmid H R, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Schmid D, Vernazza P, Kahlert C R, Kohler P. Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) Infection—Results of a Prospective Multicenter Cohort. Clinical Infectious Diseases (CID) 2022;1-9.
   
Sumer J, Flury D, Kahlert C R, Mueller N J, Risch L, Nigg S, Seneghini M, Vernazza P, Schlegel M, Kohler P. Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic-A Prospective Cohort. Int J Public Health 2022; 67:1604147.
   
Thoma R, Seneghini M, Seiffert S N, Vuichard Gysin D, Scanferla G, Haller S, Flury D, Boggian K, Kleger G R, Filipovic M, Nolte O, Schlegel M, Kohler P. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control 2022; 11:12.
   
Barnsteiner S, Baty F, Albrich W C, Babouee Flury B, Gasser M, Plüss-Suard C, Schlegel M, Kronenberg A, Kohler P, Swiss Centre For Antibiotic Resistance (ANRESIS) . Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill 2021; 26:.
   
Weber M C, Risch M, Thiel S L, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Egli K, Bodmer T, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Kahlert C R. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
   
Leal-Neto O, Egger T, Schlegel M, Flury D, Sumer J, Albrich W, Babouee Flury B, Kuster S, Vernazza P, Kahlert C R, Kohler P. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study. JMIR Public Health Surveill 2021; 7:e33576.
   
Kohler P, Guesewell S, Seneghini M, Egger T, Leal O, Brucher A, Lemmenmeier E, Möller J C, Rieder P, Ruetti M, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, Kuster S, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert C R. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study. BMC Med 2021; 19:270.
   
Baerlocher S, Helfenstein S, Mahr A, Crippa S, Garcia Boy R, Kahlert C R, Yurttas T, Hatz C, Kohler P. Leptospirosis Followed by Kawasaki-Like Disease: Case Report From an Adult Swiss Patient and Review of the Literature. Open Forum Infect Dis 2021; 8:ofab088.
   
Héquet D, Kessler S, Rettenmund G, Lemmenmeier E, Qalla-Widmer L, Gardiol C, Münzer T, Schlegel M, Petignat C, Kohler P. Healthcare-associated infections and antibiotic use in long-term care residents from two geographical regions in Switzerland. J Hosp Infect 2021; 117:172-178.
   
Sieber P, Flury D, Guesewell S, Albrich W, Boggian K, Gardiol C, Schlegel M, Sieber R, Vernazza P, Kohler P. Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study. BMC Infect Dis 2021; 21:271.
   
Hasan Ali O, Bomze D, Risch L, Brugger S D, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C R, Vernazza P, Bühler P K, Schüpbach R A, Gómez-Mejia A, Popa A M, Bergthaler A, Penninger J M, Flatz L. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:e2869-e2874.
   
Michels L, Hörburger D, Brenner R, Walter A L, Mühlethaler K, Kohler P. Radiologischer Zufallsbefund nach Südafrikareise. Swiss Medical Forum 2021; 2021:456-458.
   
Kahlert C R, Persi R, Guesewell S, Egger T, Leal-Neto O B, Sumer J, Flury D, Brucher A, Lemmenmeier E, Möller J C, Rieder P, Stocker R, Vuichard-Gysin D, Wiggli B, Albrich W, Babouee Flury B, Besold U, Fehr J, Kuster S P, McGeer A, Risch L, Schlegel M, Friedl A, Vernazza P, Kohler P. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Clin Microbiol Infect 2021; 27:1336-1344.
   
Kohler P, Wolfensberger A, Stampf S, Brönnimann A, Boggian K, Van Delden C, Favre M, Hirzel C, Khanna N, Kuster S P, Manuel O, Neofytos D, Ragozzino S, Schreiber P W, Walti L, Mueller N J, Swiss Transplant Cohort Study . Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018. Antimicrob Resist Infect Control 2021; 10:50.
   
Kohler P, Jonsdottir H R, Risch L, Vernazza P, Ackermann-Gäumann R, Kahlert C R. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study. Sci Rep 2021; 11:24198.
   
Maraolo A E, Corcione S, Grossi A, Signori A, Alicino C, Hussein K, Trecarichi E M, Viale P, Timsit J F, Veeraraghavan B, Villegas M V, Rahav G, Daikos G L, Vardakas K Z, Roilides E, Uhlemann A C, Ghafur A K, Mornese Pinna S, Bassetti M, Kohler P, Giacobbe D R. The Impact of Carbapenem Resistance on Mortality in Patients With Klebsiella Pneumoniae Bloodstream Infection: An Individual Patient Data Meta-Analysis of 1952 Patients. Infect Dis Ther 2021;.
   
Kohler P, Seiffert S N, Kessler S, Rettenmund G, Lemmenmeier E, Qalla Widmer L, Nolte O, Seth-Smith H M B, Albrich W, Babouee Flury B, Gardiol C, Harbarth S, Münzer T, Schlegel M, Petignat C, Egli A, Héquet D. Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents. J Am Med Dir Assoc 2021;.
   
Volling C, Ahangari N, Bartoszko J J, Coleman B L, Garcia-Jeldes F, Jamal A J, Johnstone J, Kandel C, Kohler P, Maltezou H C, Maze Dit Mieusement L, McKenzie N, Mertz D, Monod A, Saeed S, Shea B, Stuart R L, Thomas S, Uleryk E, McGeer A. Are Sink Drainage Systems a Reservoir for Hospital-Acquired Gammaproteobacteria Colonization and Infection? A Systematic Review. Open Forum Infect Dis 2020; 8:ofaa590.
   
Von Dach E, Albrich W, Brunel A S, Prendki V, Cuvelier C, Flury D, Gayet-Ageron A, Huttner B, Kohler P, Lemmenmeier E, McCallin S, Rossel A, Harbarth S, Kaiser L, Bochud P Y, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
   
West E A, Anker D, Amati R, Richard A, Wisniak A, Butty A, Albanese E, Bochud M, Chiolero A, Crivelli L, Cullati S, D'Acremont V, Epure A M, Fehr J, Flahault A, Fornerod L, Frank I, Frei A, Michel G, Gonseth S, Guessous I, Imboden M, Kahlert C R, Kaufmann L, Kohler P, Mösli N, Paris D, Probst-Hensch N, Rodondi N, Stringhini S, Vermes T, Vollrath F, Puhan M A, Corona Immunitas Research Group . Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland. Int J Public Health 2020;.
   
Kovac M, Risch L, Thiel S, Weber M, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Ferrara F, Bodmer T, Egli K, Imperiali M, Heer S, Salimi Y, Renz H, Kohler P, Vernazza P, Kahlert C R, Paprotny M, Risch M. EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA). Diagnostics (Basel) 2020; 10:.
   
Lins C, Bucher C, Sawatzki M, Neuweiler J, Kohler P. A 67-year-old Man With Dysphagia and Weight Loss After Travel to Southeast Asia: Disseminated histoplasmosis. Clinical Infectious Diseases 2020; 712:710-713.
   
Kohler P, Tijet N, Kim H C, Johnstone J, Edge T, Patel S N, Seah C, Willey B, Coleman B, Green K, Armstrong I, Katz K, Muller M P, Powis J, Poutanen S M, Richardson D, Sarabia A, Simor A, McGeer A, Melano R G, Toronto Invasive Bacterial Diseases Network (TIBDN) . Dissemination of Verona Integron-encoded Metallo-β-lactamase among clinical and environmental Enterobacteriaceae isolates in Ontario, Canada. Sci Rep 2020; 10:18580.
   
Buckrell S, Coleman B L, McNeil S A, Katz K, Muller M P, Simor A, Loeb M, Powis J, Kuster S P, Di Bella J M, Coleman K K, Drews S J, Kohler P, McGeer A, Canadian Healthcare Worker Study Group . Sources of viral respiratory infections in Canadian acute care hospital healthcare personnel. J Hosp Infect 2020;.
   
Kohler P, Kahlert C R, Sumer J, Flury D, Guesewell S, Leal-Neto O B, Notter J, Albrich W, Babouee Flury B, McGeer A, Kuster S, Risch L, Schlegel M, Vernazza P. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study. Infect Control Hosp Epidemiol 2020; 42:604-608.
   
Schaffner A, Risch L, Aeschbacher S, Risch C, Weber M C, Thiel S L, Jüngert K, Pichler M, Grossmann K, Wohlwend N, Lung T, Hillmann D, Bigler S, Bodmer T, Imperiali M, Renz H, Kohler P, Vernazza P, Kahlert C R, Twerenbold R, Paprotny M, Conen D, Risch M. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. J Clin Med 2020; 9:.
   
Jamal A J, Faheem A, Farooqi L, Zhong X Z, Armstrong I, Boyd D A, Borgundvaag E, Coleman B L, Green K, Jayasinghe K, Johnstone J, Katz K, Kohler P, Salian C, Mataseje L, Melano R, Muller M P, Mulvey M R, Nayani S, Patel S N, Paterson A, Poutanen S, Rebbapragada A, Richardson D, Sarabia A, Shafinaz S, Simor A E, Willey B M, Wisely L, McGeer A J. Household Transmission of Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada. Clin Infect Dis 2020;.
   
Crippa S, Kägi G, Graf L, Meyer Sauteur P M, Kohler P. Stroke in a young adult with mild COVID-19 suggesting endotheliitis. New Microbes New Infect 2020;100781.
   
Risch M, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Egli K, Bodmer T, Imperiali M, Salimi Y, Fleisch F, Cusini A, Renz H, Kohler P, Vernazza P, Kahlert C R, Paprotny M, Risch L. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int 2020; 2020:9878453.
   
Baron R C, Risch L, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Bigler S, Egli K, Ferrara F, Bodmer T, Imperiali M, Heer S, Renz H, Flatz L, Kohler P, Vernazza P, Kahlert C R, Paprotny M, Risch M. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study. Clin Chem Lab Med 2020; 58:2131-2140.
   
Seiffert S N, Wüthrich D, Gerth Y, Egli A, Kohler P, Nolte O. First clinical case of KPC-3-producing in Europe. New Microbes New Infect 2019; 29:100516.
   
Fulchini R, Albrich W, Kronenberg A, Egli A, Kahlert C R, Schlegel M, Kohler P. Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland - a systematic review. Epidemiol Infect 2019; 147:e259.
   
Jiang L, McGeer A, McNeil S, Katz K, Loeb M, Muller M P, Simor A, Powis J, Kohler P, Di Bella J M, Coleman B L, Canadian Healthcare Worker Study Group . Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010-2011 to 2013-2014. Infect Control Hosp Epidemiol 2019; 40:889-896.
   
Jamal A J, Garcia-Jeldes F, Baqi M, Borgia S, Johnstone J, Katz K, Kohler P, Muller M P, McGeer A J, CPE Investigators Of The Toronto Invasive Bacterial Diseases Network . Infection prevention and control practices related to carbapenemase-producing Enterobacteriaceae (CPE) in acute-care hospitals in Ontario, Canada. Infect Control Hosp Epidemiol 2019; 40:1006-1012.
   
Kohler P, Fulchini R, Albrich W, Egli A, Balmelli C, Harbarth S, Héquet D, Kahlert C R, Kuster S P, Petignat C, Schlegel M, Kronenberg A. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017. Antimicrob Resist Infect Control 2018; 7:88.
   
Kohler P, Melano R G, Patel S N, Shafinaz S, Faheem A, Coleman B L, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller M P, Powis J, Poutanen S M, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A, Toronto Invasive Bacterial Diseases Network (TIBDN) . Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada. Emerging Infect Dis 2018; 24:1674-1682.
   
Fulchini R, Kohler P, Kahlert C R, Albrich W, Kuhn R, Hoffmann M, Schlegel M. Hand hygiene adherence in relation to influenza season during 6 consecutive years. Am J Infect Control 2018;.
   
Lapointe-Shaw L, Voruganti T, Kohler P, Thein H H, Sander B, McGeer A. Cost-effectiveness analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital inpatients. Eur J Clin Microbiol Infect Dis 2017; 36:1047-1055.
   
Sommerstein R, Kohler P, Hasse B. Global Mycobacterium chimaera outbreak: challenges for the near future. J Hosp Infect 2017; 96:207-208.
   
Feigelman R, Kahlert C R, Baty F, Rassouli F, Kleiner R L, Kohler P, Brutsche M, Von Mering C. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome 2017; 5:20.
   
Kohler P, Volling C, Green K, Uleryk E M, Shah P S, McGeer A. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis. Infect Control Hosp Epidemiol 2017;1-10.
   
Böni C, Al-Sheikh M, Hasse B, Eberhard R, Kohler P, Hasler P, Erb S, Hoffmann M, Barthelmes D, Zweifel S A. MULTIMODAL IMAGING OF CHOROIDAL LESIONS IN DISSEMINATED MYCOBACTERIUM CHIMAERA INFECTION AFTER CARDIOTHORACIC SURGERY. Retina (Philadelphia, Pa) 2017;.
   
Lemmenmeier E, Kohler P, Bruderer T, Goldenberger D, Kleger G R, Schlegel M. First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management. Infection 2014; 42:529-34.
   
Hörburger D, & Kohler P (2020). Prevention of VOMIT - Incidental finding after a holiday in South Africa. In .
   
 
page 1 of 1